SLC2A1 and neoplasm: The hub genes of the network included SLC2A1 (solute carrier family 2 member 1), CDH3 (cadherin 3), and EFHD2 (EF-hand domain family member D2), whose expression increased with tumor stage and was associated with a lower survival rate.